These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28803922)

  • 21. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion.
    Salim M; Fraser-Miller SJ; Be Rziņš KR; Sutton JJ; Ramirez G; Clulow AJ; Hawley A; Beilles S; Gordon KC; Boyd BJ
    Mol Pharm; 2020 Mar; 17(3):885-899. PubMed ID: 32011151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of neonatal and infant enterostomy fluids.
    de Waal T; Brouwers J; Mols R; Hoffman I; Rayyan M; Augustijns P
    Int J Pharm; 2023 May; 639():122943. PubMed ID: 37059240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.
    Paixão P; Bermejo M; Hens B; Tsume Y; Dickens J; Shedden K; Salehi N; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Wysocki J; Wen B; Lee A; Frances A; Amidon GE; Yu A; Benninghoff G; Löbenberg R; Talattof A; Sun D; Amidon GL
    Mol Pharm; 2018 Dec; 15(12):5468-5478. PubMed ID: 30417648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
    Keemink J; Mårtensson E; Bergström CAS
    Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.
    Pacifici GM
    Paediatr Drugs; 2012 Aug; 14(4):233-46. PubMed ID: 22702741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
    Salim M; Khan J; Ramirez G; Clulow AJ; Hawley A; Ramachandruni H; Boyd BJ
    Mol Pharm; 2018 Aug; 15(8):3535-3544. PubMed ID: 29932660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oral solid dosage form for furosemide oral administration.
    Perioli L; D'Alba G; Pagano C
    Eur J Pharm Biopharm; 2012 Apr; 80(3):621-9. PubMed ID: 22230797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
    Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Miniaturized transfer models to predict the precipitation of poorly soluble weak bases upon entry into the small intestine.
    Klein S; Buchanan NL; Buchanan CM
    AAPS PharmSciTech; 2012 Dec; 13(4):1230-5. PubMed ID: 22968547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.
    Koenigsknecht MJ; Baker JR; Wen B; Frances A; Zhang H; Yu A; Zhao T; Tsume Y; Pai MP; Bleske BE; Zhang X; Lionberger R; Lee A; Amidon GL; Hasler WL; Sun D
    Mol Pharm; 2017 Dec; 14(12):4295-4304. PubMed ID: 28937221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of positive food effect: Bioavailability enhancement of BCS class II drugs.
    Raman S; Polli JE
    Int J Pharm; 2016 Jun; 506(1-2):110-5. PubMed ID: 27067239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permeation studies through porcine small intestine of furosemide solutions for personalised paediatric administration.
    Provenza N; Calpena AC; Mallandrich M; Sánchez A; Egea MA; Clares B
    Int J Pharm; 2014 Nov; 475(1-2):208-13. PubMed ID: 25178830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
    Carrière F
    Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo assessment of novel furosemide gastro-mucoadhesive delivery system based on a kind of anion ion-exchange fiber.
    Yao H; Wang S; Sun Y; Liu H; Li S
    Drug Dev Ind Pharm; 2009 May; 35(5):548-54. PubMed ID: 18946794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.
    Salim M; Ramirez G; Peng KY; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2020 Jul; 17(7):2749-2759. PubMed ID: 32574056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.
    Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):623-40. PubMed ID: 6678312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.